• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼古丁新型口腔喷雾给药的单剂量药代动力学。

Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.

机构信息

Clinical Pharmacology, McNeil AB, Karl XII gatan 5, S-22220 Lund, Sweden.

出版信息

Nicotine Tob Res. 2011 Dec;13(12):1176-82. doi: 10.1093/ntr/ntr139. Epub 2011 Aug 17.

DOI:10.1093/ntr/ntr139
PMID:21849415
Abstract

INTRODUCTION

As the efficacy of nicotine replacement therapy might be improved by faster systemic nicotine uptake, a new nicotine mouth spray has been developed. The current study was performed to evaluate the single-dose pharmacokinetics of nicotine at 3 doses of the mouth spray and to compare the speed of nicotine uptake from the spray versus nicotine lozenge and gum.

METHODS

In a randomized crossover study, 45 healthy adult smokers received single doses of nicotine mouth spray 1, 2, and 4 mg, nicotine lozenge 4 mg, and nicotine gum 4 mg on separate occasions. Blood samples were collected for 12 hr to determine pharmacokinetic variables.

RESULTS

Mean plasma nicotine concentrations during the first 10 min, measured using area under the curve (AUC(10 min)), were 3 times as high with spray 4 mg as with lozenge or gum. The AUC(10 min) with 2 and 1 mg doses of spray, respectively, was twice and 1.5 times as high as the AUC(10 min) with lozenge or gum. The maximum baseline-corrected plasma nicotine concentration (cC(max)) with 4 mg spray exceeded that for lozenge and gum by 34% and 20%; the median time to reach C(max) was 10-12.5 min for the 3 doses of spray, 45 min for lozenge, and 30 min for gum. The mean baseline-corrected area under the plasma nicotine concentration-versus-time curve (cAUC(∞)) with 4 mg spray was 15% higher than that with gum but did not differ significantly from that with lozenge.

CONCLUSION

Nicotine delivered via the mouth spray is absorbed considerably faster than nicotine given via gum or lozenge.

摘要

简介

由于尼古丁替代疗法的疗效可能因更快的全身尼古丁吸收而提高,因此开发了一种新的尼古丁口腔喷雾。本研究旨在评估 3 种剂量的尼古丁口腔喷雾的单剂量药代动力学,并比较喷雾与尼古丁含片和尼古丁胶的尼古丁吸收速度。

方法

在一项随机交叉研究中,45 名健康成年吸烟者在不同时间分别接受了 1、2 和 4mg 的尼古丁口腔喷雾、4mg 的尼古丁含片和 4mg 的尼古丁胶的单次剂量。采集了 12 小时的血样以确定药代动力学变量。

结果

使用曲线下面积(AUC(10 分钟))测量的前 10 分钟内,喷雾 4mg 时的平均血浆尼古丁浓度是含片或口香糖的 3 倍。分别使用 2mg 和 1mg 剂量的喷雾的 AUC(10 分钟)是含片或口香糖的 2 倍和 1.5 倍。喷雾 4mg 时的最大基线校正血浆尼古丁浓度(cC(max))比含片和口香糖分别高出 34%和 20%;喷雾 3 个剂量的 C(max)中位达峰时间为 10-12.5 分钟,含片为 45 分钟,口香糖为 30 分钟。喷雾 4mg 时的基线校正后的血浆尼古丁浓度-时间曲线下面积(cAUC(∞))平均比口香糖高 15%,但与含片无显著差异。

结论

与口香糖或含片相比,口腔喷雾给予的尼古丁吸收速度明显更快。

相似文献

1
Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.尼古丁新型口腔喷雾给药的单剂量药代动力学。
Nicotine Tob Res. 2011 Dec;13(12):1176-82. doi: 10.1093/ntr/ntr139. Epub 2011 Aug 17.
2
Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.与 4 毫克尼古丁聚醋酸乙烯酯咀嚼胶相比,瑞典部分鼻烟的尼古丁传递和主观效应。
Nicotine Tob Res. 2011 Jul;13(7):573-8. doi: 10.1093/ntr/ntr044. Epub 2011 Mar 31.
3
Pharmacokinetics of a nicotine polacrilex lozenge.尼古丁聚半乳糖醛酸酶含片的药代动力学
Nicotine Tob Res. 2003 Oct;5(5):635-44. doi: 10.1080/1462220031000158690.
4
A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy.
Respiration. 2007;74(2):196-201. doi: 10.1159/000097136. Epub 2006 Nov 14.
5
Single-Dose and Multiple-Dose Pharmacokinetics of Nicotine 6 mg Gum.6毫克尼古丁口香糖的单剂量和多剂量药代动力学
Nicotine Tob Res. 2017 Apr 1;19(4):477-483. doi: 10.1093/ntr/ntw211.
6
Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
.三种新型4毫克尼古丁含片的药代动力学特征
Int J Clin Pharmacol Ther. 2018 Mar;56(3):113-119. doi: 10.5414/CP203097.
7
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).1毫克和2毫克酒石酸尼古丁含片(Nicotinell)随机对照试验的药代动力学、安全性及疗效
BMC Clin Pharmacol. 2007 Oct 8;7:11. doi: 10.1186/1472-6904-7-11.
8
Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.两种尼古丁透皮系统(21 毫克/24 小时贴片和 25 毫克/16 小时贴片)的药代动力学比较:一项在成年吸烟者中进行的随机、开放标签、单剂量、两周期交叉研究。
Clin Ther. 2010 Jun;32(6):1140-8. doi: 10.1016/j.clinthera.2010.06.008.
9
Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study.与2毫克尼古丁咀嚼胶相比,使用四种不同类型瑞典口含烟后的稳态尼古丁血浆水平:一项交叉研究。
Nicotine Tob Res. 2005 Jun;7(3):397-403. doi: 10.1080/14622200500125468.
10
Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.与尼古丁口香糖相比,尼古丁含片在有基础疾病的成年吸烟者中的安全性概况:一项为期12周的随机开放标签研究。
Clin Ther. 2005 Oct;27(10):1571-87. doi: 10.1016/j.clinthera.2005.10.008.

引用本文的文献

1
The effect of nicotine on threat avoidance behaviour in healthy non-smokers.尼古丁对健康非吸烟者威胁回避行为的影响。
Psychopharmacology (Berl). 2025 Apr 22. doi: 10.1007/s00213-025-06789-9.
2
Acute Effects of Nicotine on Non-Drug-Related Reward in Smokers and Non-Smokers.尼古丁对吸烟者和非吸烟者非药物相关奖赏的急性影响。
Nicotine Tob Res. 2025 Apr 22;27(5):815-821. doi: 10.1093/ntr/ntae278.
3
Effect of nicotine mouth spray on urges to vape: A randomized, placebo-controlled, pharmacodynamic clinical trial in exclusive e-cigarette users.
尼古丁口腔喷雾对电子烟吸食冲动的影响:一项针对纯电子烟使用者的随机、安慰剂对照药效学临床试验。
Addiction. 2025 Jan;120(1):95-105. doi: 10.1111/add.16669. Epub 2024 Sep 24.
4
A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products.一项评估口服尼古丁袋和两种尼古丁替代疗法产品的尼古丁药代动力学的随机研究。
Sci Rep. 2022 Apr 28;12(1):6949. doi: 10.1038/s41598-022-10544-x.
5
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.健康吸烟者静脉内、口服、颊部和经皮给药后尼古丁群体药代动力学。
Clin Pharmacokinet. 2021 Apr;60(4):541-561. doi: 10.1007/s40262-020-00960-5. Epub 2020 Dec 23.
6
Effect of nicotine lozenge use prior to smoking cue presentation on craving and withdrawal symptom severity.吸烟线索出现前使用尼古丁含片对渴望感和戒断症状严重程度的影响。
Drug Alcohol Depend. 2020 Jan 1;206:107706. doi: 10.1016/j.drugalcdep.2019.107706. Epub 2019 Nov 2.
7
Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System.评价新型尼古丁传递系统使用后的尼古丁药代动力学和主观效应。
Nicotine Tob Res. 2018 Mar 6;20(4):458-465. doi: 10.1093/ntr/ntx093.
8
Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokers.低依赖吸烟者单次给药治疗后,尼古丁口腔可溶性薄膜与尼古丁含片缓解吸烟线索诱发的急性渴望疗效比较。
Psychopharmacology (Berl). 2014 Nov;231(22):4383-91. doi: 10.1007/s00213-014-3586-2. Epub 2014 Apr 30.
9
Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studies.描述尼古丁对胎盘发育的不良影响:体内和体外研究。
Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E443-56. doi: 10.1152/ajpendo.00478.2013. Epub 2013 Dec 24.
10
Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.用于戒烟和减少危害的尼古丁替代疗法新型给药系统:原理及相较于现有系统优势的证据
CNS Drugs. 2013 Dec;27(12):1007-19. doi: 10.1007/s40263-013-0116-4.